Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Eton Pharmaceuticals (ETON) Accumulated Depreciation & Amortization (2018 - 2025)

Eton Pharmaceuticals' Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $486000.0 for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 8.97% to $486000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $486000.0, a 8.97% increase, with the full-year FY2025 number at $486000.0, up 8.97% from a year prior.
  • Accumulated Depreciation & Amortization hit $486000.0 in Q4 2025 for Eton Pharmaceuticals, up from $446000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for ETON hit a ceiling of $486000.0 in Q4 2025 and a floor of $21000.0 in Q1 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $257294.1 across 5 years, with a median of $365000.0 in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: crashed 80.56% in 2021 and later soared 1638.1% in 2023.
  • Tracing ETON's Accumulated Depreciation & Amortization over 5 years: stood at $155000.0 in 2021, then tumbled by 57.42% to $66000.0 in 2022, then soared by 498.48% to $395000.0 in 2023, then increased by 12.91% to $446000.0 in 2024, then grew by 8.97% to $486000.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for ETON at $486000.0 in Q4 2025, $446000.0 in Q4 2024, and $434000.0 in Q3 2024.